查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1771629

花生过敏治疗市场规模、份额、趋势分析报告：按药物类别、给药途径、分销管道、地区、细分市场预测，2025-2033

Peanut Allergy Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antihistamines, Epinephrine, Immunotherapies), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

花生过敏治疗市场的成长与趋势：

根据 Grand View Research 的一份新报告，全球花生过敏治疗市场预计到 2033 年将达到 14.615 亿美元。

预计 2025 年至 2033 年期间市场复合年增长率为 11.43%。推动市场成长的关键因素包括强大的产品平臺、高疾病盛行率、药物输送系统的进步以及主要企业的策略性倡议。

主要市场参与企业正在透过各种策略强化其花生过敏治疗产品线。例如，Aravax 于 2022 年 12 月启动 B 轮资金筹措，获得澳洲知名医疗保健企业家 Tenmile 和 Brandon Capital 的 2,000 万美元投资。这笔资金筹措将使 Aravax 能够启动 PVX108 针对花生过敏患者的 II 期临床试验。预计这笔资金筹措将用于推进研发项目。

越来越多的花生过敏治疗药物核准也刺激了市场发展。 2020年1月，美国食品药物管理局(FDA) 批准了由Aimmune Therapeutics, Inc. 开发的PALFORZIA [花生（Arachis hypogaea）过敏原粉-dnfp]。 PALFORZIA是第一个核准花生过敏患者的免疫疗法。该药物是一种口服免疫疗法，旨在减少因摄入花生引起的过敏反应，包括过敏性休克。该药物适用于已确诊过敏的患者，建议4至17岁儿童增加初始剂量。

截至2023年第一季，多款前景研发线产品正在临床开发中，包括DBV Technologies的Viaskin Peanut、Dupixient的CA002以及赛诺菲与再生元合作的Camallegr。此外，ADP101、VE416、INP20和CNP-201等产品也正在开发中。预计这些药物的引入将有助于预测期内市场的成长和扩张。

花生过敏治疗市场报告重点

  • 2024 年，肾上腺素领域占据了主要市场占有率。过敏反应治疗的标准是肾上腺素自动注射器，这对紧急过敏管理也至关重要。
  • 根据给药途径，注射剂预计将在 2024 年占据市场主导地位，这是因为人们越来越重视以患者为中心的护理，这推动了实用、痛苦较小且患者更易于使用的注射疗法的发展，包括探索注射疗法的替代输送系统，如可穿戴技术和自动注射器。
  • 按分销管道划分，医院药房在 2024 年占据了最大的市场占有率。医院药房专注于为花生过敏患者提供支援和资讯。
  • 北美在这个市场上占据着强势地位，因为这里拥有许多製药公司、学术机构和研究机构，这些公司、学术机构和研究机构目前正在研究新的治疗策略来解决花生过敏的根本原因，包括基因疗法、生技药品和其他免疫调节干预措施。

目录

第一章调查方法与范围

第二章执行摘要

3. 花生过敏治疗市场变数、趋势与范围

  • 市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析-波特五力分析
    • PESTLE分析
    • 管道分析
    • 专利到期分析
    • 定价分析

4. 花生过敏治疗市场-药物类业务分析

  • 2024 年及 2033 年药品类别市场占有率
  • 药品类别细分仪表板
  • 2021 年至 2033 年按药物类别分類的市场规模、预测与趋势分析
  • 抗组织胺药
  • 肾上腺素
  • 免疫疗法
  • 其他的

5. 花生过敏治疗市场：给药途径业务分析

  • 2024年及2033年给药途径市场占有率
  • 给药途径细分仪表板
  • 2021 年至 2033 年按药物类别分類的市场规模、预测与趋势分析
  • 口服
  • 注射
  • 其他的

6. 花生过敏治疗市场：通路业务分析

  • 2024年及2033年分销通路市场占有率
  • 分销通路细分仪表板
  • 按分销管道分類的市场规模、预测和趋势分析（2021-2033 年）
  • 医院药房
  • 零售药局
  • 其他的

7. 花生过敏治疗市场：区域估计与趋势分析

  • 2024 年及 2033 年区域市场占有率分析
  • 区域市场仪表板
  • 2021-2033年市场规模与预测趋势分析
  • 北美洲
    • 按国家/地区，2021-2033 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 参与者概览
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Aimmune Therapeutics（Nestle Health Science）
    • DBV Technologies
    • Sanofi
    • ALK-Abello
    • Prota Therapeutics
    • Camallergy
    • Aravax
    • Arch Pharmalabs
    • Genentech
Product Code: GVR-4-68040-097-6

Peanut Allergy Treatment Market Growth & Trends:

The global peanut allergy treatment market size is expected to reach USD 1,461.5 million by 2033, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 11.43% from 2025 to 2033. Some of the key factors propelling the market growth include a robust product pipeline, high disease prevalence, advancement in the drug delivery system, and strategic initiatives by key players.

Key market players are bolstering their pipeline for peanut allergy treatment through various strategies. For instance, Aravax initiated its series B funding round in December 2022, securing a USD 20 million investment from renowned Australian healthcare entrepreneurs Tenmile and Brandon Capital. This financing will enable Aravax to commence phase II clinical trials of PVX108, targeting individuals who experience allergic reactions to peanuts. Such fundings are expected to drive advancements in research and development programs.

The market is stimulated by the increasing number of product approvals for peanut allergy treatment. In January 2020, the U.S. Food and Drug Administration (FDA) granted authorization to PALFORZIA [Peanut (Arachis hypogaea) Allergen Powder-dnfp], developed by Aimmune Therapeutics, Inc. PALFORZIA is the first immunotherapy medication approved for individuals with peanut allergies. It is an oral immune therapy designed to reduce allergy responses, including anaphylaxis triggered by accidental peanut ingestion. It is intended for individuals who have a confirmed allergy, with initial dose escalation recommended for children aged four to 17.

As of the first quarter of 2023, several promising pipeline products are undergoing clinical development. These include Viaskin Peanut by DBV Technologies, CA002 by Dupixient, and Camallegr, a collaborative effort between Sanofi and Regeneron. Additionally, other assets such as ADP101, VE416, INP20, and CNP-201 are also in development. The introduction of these medications is anticipated to contribute to the growth and expansion of the market during the projected forecast period.

Peanut Allergy Treatment Market Report Highlights:

  • The epinephrine segment held the major market share in 2024. The standard of care for anaphylaxis treatment has been epinephrine auto-injectors, which are also essential in the management of allergies in emergency situations.
  • By route of administration, the injectable segment dominated the market in 2024 owing to the development of injectable treatments that are practical, less painful, and easier to use for patients is being pursued in response to the growing emphasis on patient-centered care. This includes looking at alternative delivery systems for injectable therapies, such as wearable technology or auto-injectors.
  • By distribution channel, the hospital pharmacy segment held the largest market share in 2024. Hospital pharmacies put more of an emphasis on offering patient support and information for people with peanut allergies.
  • North America has established a strong regional position in the market. This is due to the presence of numerous pharmaceutical companies, academic institutions, and research organizations currently looking into new therapeutic strategies to address the underlying causes of peanut allergies, including gene therapy, biologics, and other immunomodulatory interventions.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Route of Administration
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Peanut Allergy Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Peanut Allergy Treatment Market: Drug Class Business Analysis

  • 4.1. Drug Class Market Share, 2024 & 2033
  • 4.2. Drug Class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
  • 4.4. Antihistamines
    • 4.4.1. Antihistamines Market, 2021 - 2033 (USD Million)
  • 4.5. Epinephrine
    • 4.5.1. Epinephrine Market, 2021 - 2033 (USD Million)
  • 4.6. Immunotherapies
    • 4.6.1. Immunotherapies Market, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Peanut Allergy Treatment Market: Route of Administration Business Analysis

  • 5.1. Route of Administration Market Share, 2024 & 2033
  • 5.2. Route of Administration Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral Market, 2021 - 2033 (USD Million)
  • 5.5. Injectable
    • 5.5.1. Injectable Market, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Peanut Allergy Treatment Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2033
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Peanut Allergy Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America Peanut Allergy Treatment Market Estimates And Forecasts, By Country, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Framework
      • 7.4.2.5. U.S. Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Framework
      • 7.4.3.5. U.S. Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Framework
      • 7.4.4.5. Mexico Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Framework
      • 7.5.2.5. Uk Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Framework
      • 7.5.3.5. Germany Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Framework
      • 7.5.4.5. France Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Reimbursement Framework
      • 7.5.5.5. Italy Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement Framework
      • 7.5.6.5. Spain Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Framework
      • 7.5.7.5. Denmark Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Target Disease Prevalence
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Framework
      • 7.5.8.5. Sweden Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Target Disease Prevalence
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Framework
      • 7.5.9.5. Norway Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Framework
      • 7.6.2.5. Japan Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Framework
      • 7.6.3.5. China Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Framework
      • 7.6.4.5. India Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Framework
      • 7.6.5.5. Australia Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Framework
      • 7.6.6.5. South Korea Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Target Disease Prevalence
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Framework
      • 7.6.7.5. Thailand Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Target Disease Prevalence
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Framework
      • 7.7.2.5. Japan Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Target Disease Prevalence
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Framework
      • 7.7.3.5. China Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Peanut Allergy Treatment Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Target Disease Prevalence
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Framework
      • 7.8.2.5. South Africa Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Target Disease Prevalence
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Framework
      • 7.8.3.5. Saudi Arabia Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Target Disease Prevalence
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Framework
      • 7.8.4.5. UAE Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Target Disease Prevalence
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Framework
      • 7.8.5.5. Kuwait Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Aimmune Therapeutics (Nestle Health Science)
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. DBV Technologies
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Sanofi
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. ALK-Abello
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Prota Therapeutics
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Camallergy
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Aravax
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Arch Pharmalabs
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Genentech
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Peanut Allergy Treatment market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 5 Global Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 6 North America Peanut Allergy Treatment market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 8 North America Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 9 U.S. Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 10 U.S. Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 11 Canada Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 12 Canada Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 13 Mexico Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 14 Mexico Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 15 Europe Peanut Allergy Treatment market, by country, 2021 - 2033 (USD Million)
  • Table 16 Europe Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 17 Europe Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 18 UK Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 19 UK Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 20 Germany Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 21 Germany Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 22 France Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 23 France Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 24 Italy Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 25 Italy Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 26 Spain Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 27 Spain Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 28 Norway Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 29 Norway Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 30 Denmark Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 31 Denmark Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 32 Sweden Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 33 Sweden Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific Peanut Allergy Treatment market, by country, 2021 - 2033 (USD Million)
  • Table 35 Asia Pacific Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 36 Asia Pacific Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 37 Japan Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 38 Japan Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 39 China Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 40 China Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 41 India Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 42 India Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 43 Australia Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 44 Australia Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 45 South Korea Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 46 South Korea Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 47 Thailand Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 48 Thailand Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 49 Latin America Peanut Allergy Treatment market, by country, 2021 - 2033 (USD Million)
  • Table 50 Latin America Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 51 Latin America Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 52 Brazil Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 53 Brazil Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 54 Argentina Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 55 Argentina Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 56 Middle East & Africa Peanut Allergy Treatment market, by country, 2021 - 2033 (USD Million)
  • Table 57 Middle East & Africa Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 58 Middle East & Africa Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 59 South Africa Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 60 South Africa Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 61 Saudi Arabia Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 62 Saudi Arabia Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 63 UAE Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 64 UAE Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 65 Kuwait Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 66 Kuwait Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Peanut Allergy Treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and application outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Peanut Allergy Treatment market dynamics
  • Fig. 12 Peanut Allergy Treatment market: Porter's five forces analysis
  • Fig. 13 Peanut Allergy Treatment market: PESTLE analysis
  • Fig. 14 Drug Class market, 2021 - 2033 (USD Million)
  • Fig. 15 Antihistamines market, 2021 - 2033 (USD Million)
  • Fig. 16 Epinephrine market, 2021 - 2033 (USD Million)
  • Fig. 17 Immunotherapies market, 2021 - 2033 (USD Million)
  • Fig. 18 Others market, 2021 - 2033 (USD Million)
  • Fig. 19 Route of Administration market, 2021 - 2033 (USD Million)
  • Fig. 20 Oral market, 2021 - 2033 (USD Million)
  • Fig. 21 Injectable market, 2021 - 2033 (USD Million)
  • Fig. 22 Others market, 2021 - 2033 (USD Million)
  • Fig. 23 Distribution Channel market, 2021 - 2033 (USD Million)
  • Fig. 24 Hospital Pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 25 Retail Pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 26 Others market, 2021 - 2033 (USD Million)
  • Fig. 27 Peanut Allergy Treatment market revenue, by region
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. country dynamics
  • Fig. 31 U.S. Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 32 Canada country dynamics
  • Fig. 33 Canada Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 34 Mexico country dynamics
  • Fig. 35 Mexico Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 36 Europe Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 37 UK country dynamics
  • Fig. 38 UK Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 39 Germany country dynamics
  • Fig. 40 Germany Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 41 France country dynamics
  • Fig. 42 France Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 43 Italy country dynamics
  • Fig. 44 Italy Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 45 Spain country dynamics
  • Fig. 46 Spain Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 47 Norway country dynamics
  • Fig. 48 Norway Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 49 Sweden country dynamics
  • Fig. 50 Sweden Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark country dynamics
  • Fig. 52 Denmark Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 54 Japan country dynamics
  • Fig. 55 Japan Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 56 China country dynamics
  • Fig. 57 China Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 58 India country dynamics
  • Fig. 59 India Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 60 Australia country dynamics
  • Fig. 61 Australia Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 62 South Korea country dynamics
  • Fig. 63 South Korea Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 64 Thailand country dynamics
  • Fig. 65 Thailand Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 66 Latin America Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 67 Brazil country dynamics
  • Fig. 68 Brazil Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 69 Argentina country dynamics
  • Fig. 70 Argentina Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 71 MEA Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 72 South Africa country dynamics
  • Fig. 73 South Africa Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 74 Saudi Arabia country dynamics
  • Fig. 75 Saudi Arabia Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 76 UAE country dynamics
  • Fig. 77 UAE Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 78 Kuwait country dynamics
  • Fig. 79 Kuwait Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
  • Fig. 80 Company categorization
  • Fig. 81 Company market position analysis
  • Fig. 82 Strategic framework